Compounds and compositions for the treatment of ocular disorders
Abstract:
The disclosure describes prodrugs and derivatives of prostaglandins, carbonic anhydrase inhibitors, kinase inhibitors, beta-adrenergic receptor antagonists and other drugs, as well as controlled delivery formulations containing such prodrugs and derivatives, for the treatment of ocular disorders.
Public/Granted literature
Information query
Patent Agency Ranking
0/0